A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia – Case Reports

References

• Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? The Lancet. 2020;395:1225–1228. doi:10.1016/S0140-6736(20)30627-9
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim Guidance. 2020.
   Google Scholar
• Guan W, Ni Z, Hu Y, et al. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Wang Y, Dong C, Hu Y. Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study. Radiology. 2020;19:200843. doi:10.1148/radiol.2020200843.
   Web of Science ®Google Scholar
• Hui DS, Wong KT, Ko FW, et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest. 2005;128:2247–2261. doi:10.1378/chest.128.4.2247
   PubMed Web of Science ®Google Scholar
• Chang Y-C, Chong-Jen Y, Chang S-C, et al. Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT. Radiology. 2005;236(3):1067–1075. doi:10.1148/radiol.2363040958
   PubMed Web of Science ®Google Scholar
• Zornetzer GA, Frieman MB, Rosenzweig E, et al. Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection. J Virol. 2010;84(21):11297–11309. doi:10.1128/JVI.01130-10
   PubMed Web of Science ®Google Scholar
• Lechowicz K, Drożdżal S, Machaj F, et al. COVID-19: the potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection. J Clin Med. 2020;9(6):E1917. doi:10.3390/jcm9061917
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV). 2020. Available from: https://www.cdc.gov/coronavirus/2019-nCoV/guidelines-clinical-specimens.html.opens in new tab.
   Google Scholar
• Revel MP, Parkar AP, Prosch H, et al. COVID-19 patients and the radiology department - advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). Eur Radiol. 2020. doi:10.1007/s00330-020-06865-y
   Web of Science ®Google Scholar
• Sheng G, Chen P, Wei Y. Viral infection increases the risk of idiopathic pulmonary fibrosis: a meta-analysis. Chest. 2019. doi:10.1016/j.chest.2019.10.032
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhang Y, Wang Y, et al. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol. 2020;30(8):4381–4389. doi:10.1007/s00330-020-06801-0
   PubMed Web of Science ®Google Scholar
• Naik PK, Moore BB. Viral infection and aging as cofactors for the development of pulmonary fibrosis. Expert Rev Respir Med. 2010;4(6):759–771. doi:10.1586/ers.10.73
   PubMedGoogle Scholar
• Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol. 2020;20:108427. doi:10.1016/j.clim.2020.108427
   Web of Science ®Google Scholar
• Li H, Liu L, Zhang D, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020. doi:10.1016/s0140-6736(20)30920-x
   Web of Science ®Google Scholar
• Ingraham NE, Lotfi-Emran S, Thielen BK, et al. Immunomodulation in COVID-19. Lancet Respir Med. 2020;S2213–2600(20):30226. doi:10.1016/S2213-2600(20)30226-5
   Web of Science ®Google Scholar
• Sciascia S, Aprà F, Baffa A, et al. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. Clin Exp Rheumatol. 2020.
   Web of Science ®Google Scholar
• Xu X, Han M, Li T, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci. 2020. doi:10.1073/pnas.2005615117
   Web of Science ®Google Scholar
• The RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19 — preliminary Report. NEJM. 2020. doi:10.1056/NEJMoa2021436
   Web of Science ®Google Scholar
• Sgalla G, Iovene B, Calvello M, et al. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir Res. 2018;19(1):32. doi:10.1186/s12931-018-0730-2
   PubMed Web of Science ®Google Scholar
• Wang J, Wang BG, Jang YC, et al. Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures. Zhonghua Shao Shang Za Zhi. 2020. 36:E006. doi:10.3760/cma.j.cn501120-20200307-00132
   Google Scholar
• Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med. 2017;377(6):562–572. doi:10.1056/NEJMra1608077
   PubMed Web of Science ®Google Scholar
• Cabrera-Benitez NE, Laffey JG, Parotto M, et al. Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcome. Anesthesiology. 2014;121(1):189–198. doi:10.1097/ALN.0000000000000264
   PubMed Web of Science ®Google Scholar
• Yu Z, Wang T, Zhang L, et al. WISP1 and TLR4 on macrophages contribute to ventilator-induced lung injury. Inflammation. 2020;43(2):425–432. doi:10.1007/s10753-019-01103-0
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gonzalez FJ, Chandel NS, Jain M, et al. Reactive oxygen species as signaling molecules in the development of lung fibrosis. Transl Res J Lab Clin Med. 2017;190:61–68.
   Google Scholar
• Otoupalova E, Smith S, Cheng G, et al. Oxidative stress in pulmonary fibrosis. Compr Physiol. 2020;10:509–547.
   PubMed Web of Science ®Google Scholar
• Yang Y, Tang H. Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia. Cell Mol Immunol. 2016;13:432–442. doi:10.1038/cmi.2016.1
   PubMed Web of Science ®Google Scholar
• Sambataro G, Sambataro D, Torrisi SE, et al. Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients. Respir Med. 2019;150:154–160. doi:10.1016/j.rmed.2019.03.011
   PubMed Web of Science ®Google Scholar
• Available from: https://www.clinicaltrials.gov/ct2/results?cond=Covid19&term=lung+fibrosis&cntry=&state=&city=&dist=. Accessed October 14, 2020.
   Google Scholar
• Jackson LA, Anderson EJ, Rouphael NG. et al. An mRNA vaccine against SARS-CoV-2 - preliminary report. N Engl J Med. 2020. NEJMoa2022483. doi:10.1056/NEJMoa2022483
   PubMed Web of Science ®Google Scholar
• Xiaoneng M, Jian W, Zhuquan S, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;12;2001217. doi:10.1183/13993003.01217-2020
   Web of Science ®Google Scholar